Skip to main content

ESTUDIO GENETICO Y GENOMICO EN PACIENTES INFERTILES Y PACIENTES CON TUMOR TESTICULAR DE CELULAS GERMINALES: DESARROLLO DE NUEVAS HERRAMIENTAS PARA UN DIAGNOSTICO PRECOZ

PI17/01822

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO
Execution centre FUNDACION PUIGVERT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia

  • Krausz, Csilla|||0000-0001-6748-8918
  • Riera-Escamilla, Antoni|||0000-0002-4485-3094
  • Chianese, Chiara|||0000-0002-8952-0584
  • Moreno-Mendoza, Daniel
  • Ars, Elisabet|||0000-0002-4118-4358
  • Rajmil Marquenson, Osvlado|||0000-0003-1987-9206
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Rodríguez, Inés
  • Badell Serra, Isabel|||0000-0001-6546-2175
  • Ruiz-Castañé, Eduardo|||0000-0002-7469-4610
  • Surralles, Jordi|||0000-0002-4041-7519
Purpose: in about 10% of patients affected by Fanconi anemia (FA) the diagnosis is delayed until adulthood, and the presenting symptom in these "occult" FA cases is often a solid cancer and cancer treatment-related toxicity. Highly predictive clinical parameter(s) for diagnosing such an adult-onset cases are missing. - Methods: (1) Exome sequencing (ES), (2) Sanger sequencing of FANCA, (3) diepoxybutane (DEB)-induced chromosome breakage test. - Results: ES identified a pathogenic homozygous FANCA variant in a patient affected by Sertoli cell-only syndrome (SCOS) and in his azoospermic brother. Although they had no overt anemia, chromosomal breakage test revealed a reverse somatic mosaicism in the former and a typical FA picture in the latter. In 27 selected SCOS cases, 1 additional patient showing compound heterozygous pathogenic FANCA variants was identified with positive chromosomal breakage test. - Conclusion: we report an extraordinarily high frequency of FA in a specific subgroup of azoospermic patients (7.1%). The screening for FANCA pathogenic variants in such patients has the potential to identify undiagnosed FA before the appearance of other severe clinical manifestations of the disease. The definition of this high-risk group for "occult" FA, based on specific testis phenotype with mild/borderline hematological alterations, is of unforeseen clinical relevance.